CSF3 and Absence of circulating granulocytes: A systematic review of the use of granulocyte colony-stimulating factor in clozapine rechallenges by [62] found that patients who had previously experienced CIA were treated with granulocyte colony-stimulating factor (G-CSF), such that, for example, filgrastim might shorten the period of agranulocytosis by approximately five days.